122 related articles for article (PubMed ID: 18248391)
1. Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005).
Lee JK; Song SH; Kim I; Lee KH; Kim BG; Kim JW; Kim YT; Park SY; Cha MS; Kang SB
Int J Gynecol Cancer; 2008; 18(5):916-20. PubMed ID: 18248391
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
4. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
[TBL] [Abstract][Full Text] [Related]
5. [Histologic classification and prognostic implication of pseudomyxoma peritonei].
Guo AT; Wei LX; Song X
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):474-9. PubMed ID: 17845762
[TBL] [Abstract][Full Text] [Related]
6. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary.
Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ
Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376
[TBL] [Abstract][Full Text] [Related]
8. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
9. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
10. Female patients with pseudomyxoma peritonei: a single-institution clinicopathologic study of 35 cases.
Peng P; Keng S; Ming W; Huifang H; Linya P; Jiaxin Y
Arch Gynecol Obstet; 2014 Feb; 289(2):365-72. PubMed ID: 23949422
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
12. Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei.
Li Y; Guo A; Tang J; Wang L; Wang J; Yu D
J Ultrasound Med; 2013 Sep; 32(9):1565-70. PubMed ID: 23980216
[TBL] [Abstract][Full Text] [Related]
13. Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings.
Low RN; Barone RM; Gurney JM; Muller WD
AJR Am J Roentgenol; 2008 Mar; 190(3):656-65. PubMed ID: 18287436
[TBL] [Abstract][Full Text] [Related]
14. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
[TBL] [Abstract][Full Text] [Related]
15. Pseudomyxoma peritonei: a review of 23 cases.
Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
[TBL] [Abstract][Full Text] [Related]
16. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
[TBL] [Abstract][Full Text] [Related]
17. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
Prayson RA; Hart WR; Petras RE
Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
[TBL] [Abstract][Full Text] [Related]
19. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report.
Marquette S; Amant F; Vergote I; Moerman P
Int J Gynecol Pathol; 2006 Oct; 25(4):340-3. PubMed ID: 16990709
[TBL] [Abstract][Full Text] [Related]
20. Borderline-like mucinous tumor arising in mature cystic teratoma of the ovary associated with pseudomyxoma peritonei.
Hwang JH; So KA; Modi G; Lee JK; Lee NW; Lee KW; Kim I
Int J Gynecol Pathol; 2009 Jul; 28(4):376-80. PubMed ID: 19483624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
